Research Article
Health-Related Quality of Life in the Gender, Race, And Clinical Experience Trial
Table 2
Results from the univariate analysis to investigate factors associated with improvements in total FAHI score over 48 weeks.
| Covariate | P value |
| Baseline FAHI | <.0001 | Baseline CD4+ count | .0052 | Confirmed virologic response | .0335 | History of psychological illness | .0570 | Baseline log10 viral load | .0862 | Stage of HIV infection | .1441 | Sex | .1979 | Presence of etravirine in the OBR | .2062 | Alcohol use | .2700 | Duration of diagnosis | .2995 | Black race versus other | .3490 | Incidence of grade 2–4 AE | .4374 | Smoker | .5272 | Presence of hepatitis C antibody | .5938 | Age | .7183 | Structured treatment interruption | .7757 | Adherence | .8049 | Drug use | .9548 |
|
|
FAHI: Functional Assessment of HIV Infection; OBR: optimized background regimen; AE: adverse event.
|